ATLAS: Week 48 Results From Phase III Study of Switching to Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Patients With No Prior Virologic Failure

March 4-7, 2019; Seattle, Washington
Switch to long-acting dual therapy regimen maintains virologic suppression at Week 48.
Format: Microsoft PowerPoint (.ppt)
File Size: 177 KB
Released: March 9, 2019

Acknowledgements

Directly provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

This program is supported by independent educational grants from
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Related Content

Commentary from José Arribas, MD, on how to switch ART in patients with virologic suppression and incomplete resistance data as reported by Clinical Care Options (CCO)

José R. Arribas, MD Released: January 23, 2020

Free downloadable CCO slides on avoiding ART failure or complications due to drug interactions with antacids, H2RAs, PPIs, rifampin, or corticosteroids

David J. Back, PhD, FRCP Marta Boffito, MD, PhD, FRCP John Faragon, PharmD, BCPS, AAHIVP Paul E. Sax, MD Released: January 16, 2020

Downloadable slides from CCO HIV symposium on recent advances in ART: insights from Jose Arribas, Alexandra Calmy, Jean-Michel Molina, and Laura Waters

Jean-Michel Molina, MD, PhD
Program Director
José R. Arribas, MD Alexandra Calmy, MD, FMH, PhD Laura Waters, MD
Released: January 14, 2020

Free downloadable slides from Clinical Care Options with expert perspective on Fall 2019 HIV conference data from Drs. Chloe Orkin and Jürgen Rockstroh

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Jürgen K. Rockstroh, MD Released: January 13, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?